News

Risk mitigation in bioanalysis to maintain the integrity of drug development studies Wednesday, October 11, 2023 | 11:15 am EDT (NA) / 5:15 pm CEST | 30 min, or on-demand Don’t miss our upcoming...

Glucagon-induced insulin resistance can result in a complicated insulin-deficient state that may lead to an altered capacity of the skeletal muscle to oxidize fatty acids. Since insulin and glucagon t...

We are delighted to report that the audit results of our new bioanalytical service lab in Winston-Salem, US, have been approved. This achievement validates our commitment to maintaining the highest le...

Grand opening of Mercodia’s new Bioanalytical Service Lab in Winston-Salem’s Innovation Quarter, May 1st, 2023. The grand opening took place May 1st in Winston-Salem’s Innovation Quarter with ...

We are excited about opening a new bioanalytical service lab in Winston Salem, NC, in May 2023. With this new lab, we are broadening our capacity to provide bioassay testing for preclinical and clinic...

Building a bioanalytical strategy for asset optimization and risk management in drug development Wednesday, April 19, 2023 | 9:30am EDT (NA) / 2:30pm BST (UK) / 3:30pm CEST (EU-Central) 60 min, or on-...

Protein concentrations in samples have always been of crucial relevance for researchers and laboratory personnel. If your insulin sample concentrations are within range for your application, a variety...

It has been a great 2022, thanks to your work and your contribution to science, we have taken another step to improve human health.  We appreciate your business and look forward to being your preferr...

Bioanalytical fit-for-purpose solutions for preclinical and clinical development Biomarkers and PK/PD studies play key roles in the drug development process with the potential to improve the success r...